Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Accumulated Expenses (2023 - 2025)

Historic Accumulated Expenses for SeaStar Medical Holding (ICUCW) over the last 3 years, with Q3 2025 value amounting to $2.0 million.

  • SeaStar Medical Holding's Accumulated Expenses fell 1065.04% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 1065.04%. This contributed to the annual value of $3.2 million for FY2024, which is 10932.37% up from last year.
  • According to the latest figures from Q3 2025, SeaStar Medical Holding's Accumulated Expenses is $2.0 million, which was down 1065.04% from $1.9 million recorded in Q2 2025.
  • SeaStar Medical Holding's Accumulated Expenses' 5-year high stood at $3.3 million during Q1 2025, with a 5-year trough of $1.4 million in Q2 2023.
  • For the 3-year period, SeaStar Medical Holding's Accumulated Expenses averaged around $2.1 million, with its median value being $1.9 million (2025).
  • The largest annual percentage gain for SeaStar Medical Holding's Accumulated Expenses in the last 5 years was 11081.61% (2025), contrasted with its biggest fall of 1660.76% (2025).
  • Over the past 3 years, SeaStar Medical Holding's Accumulated Expenses (Quarter) stood at $1.5 million in 2023, then skyrocketed by 109.32% to $3.2 million in 2024, then plummeted by 35.79% to $2.0 million in 2025.
  • Its Accumulated Expenses was $2.0 million in Q3 2025, compared to $1.9 million in Q2 2025 and $3.3 million in Q1 2025.